http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0729362-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1994-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1c8646ce504e3b492147e3c166200b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_606659e3be9a848b08c2973eaef577c7
publicationDate 2000-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0729362-B1
titleOfInvention TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-alpha-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
abstract The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L- alpha -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors. In formula (I), R can be independently hydrogen or alkyl having 1 to 6 carbon atoms.
priorityDate 1993-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233720979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70298235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22858221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233306645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9805266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466071744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233305008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20069239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233728008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70298230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233052250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466478904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128614516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88191510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88263005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466478918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233058457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54079164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233304102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70172954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128984259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233720968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129366018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88142070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135

Total number of triples: 54.